Thomas Linder

Characterization of a Structural Leoligin Analog as Farnesoid X Receptor Agonist and Modulator of Cholesterol Transport

A. Atanasov, D. Schuster, V. Dirsch, 2020, Planta Medica.

Leoligin-inspired synthetic lignans with selectivity for cell-type and bioactivity relevant for cardiovascular disease

V. Dirsch, S. Schwaiger, M. Schnürch, 2019, Chemical science.